These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32529027)

  • 21. Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
    Urbiola C; Santer FR; Petersson M; van der Pluijm G; Horninger W; Erlmann P; Wollmann G; Kimpel J; Culig Z; von Laer D
    Int J Cancer; 2018 Oct; 143(7):1786-1796. PubMed ID: 29696636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
    Malilas W; Koh SS; Srisuttee R; Boonying W; Cho IR; Jeong CS; Johnston RN; Chung YH
    Cancer Gene Ther; 2013 Feb; 20(2):125-32. PubMed ID: 23306614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer.
    Patel MR; Jacobson BA; Ji Y; Drees J; Tang S; Xiong K; Wang H; Prigge JE; Dash AS; Kratzke AK; Mesev E; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
    Oncotarget; 2015 Oct; 6(32):33165-77. PubMed ID: 26431376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN; Kang CY
    Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death.
    Zhang KX; Matsui Y; Hadaschik BA; Lee C; Jia W; Bell JC; Fazli L; So AI; Rennie PS
    Int J Cancer; 2010 Aug; 127(4):830-8. PubMed ID: 19957332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
    Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
    J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
    Ahmed M; McKenzie MO; Puckett S; Hojnacki M; Poliquin L; Lyles DS
    J Virol; 2003 Apr; 77(8):4646-57. PubMed ID: 12663771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein.
    Douzandegan Y; Tahamtan A; Gray Z; Nikoo HR; Tabarraei A; Moradi A
    Osong Public Health Res Perspect; 2019 Aug; 10(4):246-252. PubMed ID: 31497497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection.
    Le Boeuf F; Niknejad N; Wang J; Auer R; Weberpals JI; Bell JC; Dimitroulakos J
    Int J Cancer; 2012 Aug; 131(3):E204-15. PubMed ID: 22173567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
    Ebert O; Harbaran S; Shinozaki K; Woo SL
    Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.
    Singh N; Ramĩrez-Carvajal L; de Los Santos T; Golding MC; Long CR
    J Interferon Cytokine Res; 2016 Jan; 36(1):37-47. PubMed ID: 26418342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.
    Wollmann G; Robek MD; van den Pol AN
    J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice.
    Moussavi M; Fazli L; Tearle H; Guo Y; Cox M; Bell J; Ong C; Jia W; Rennie PS
    Cancer Res; 2010 Feb; 70(4):1367-76. PubMed ID: 20145134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein.
    Mamizadeh Z; Kalani MR; Parsania M; Soltan Dallal MM; Moradi A
    Mol Ther Oncolytics; 2021 Dec; 23():593-601. PubMed ID: 34977336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
    Betancourt D; Ramos JC; Barber GN
    J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro.
    Jiang B; Lun X; Hao X; Wang Y; Yin X; Huang D; He W; Wang Z
    Biomed Pharmacother; 2017 Nov; 95():1201-1208. PubMed ID: 28931212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.
    van Asten SD; Raaben M; Nota B; Spaapen RM
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.